Inventor · disambiguated record
Thomas Neubauer
Also filed as: NEUBAUER THOMAS
17 granted patents·6 pending applications·18 citations·filing 2017–2023
88Inventor score
Top patents by PatentIndex Score
23 records- 0192US9988367B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jun 5, 2018·5 cites·14 claims
- 0284US10526314B2Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereofBAYER AG·Filed 2017·Granted Jan 7, 2020·3 cites·6 claims
- 0384US10472348B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Nov 12, 2019·3 cites·12 claims
- 0479US10525041B2Fluoroalkyl-substituted aryltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jan 7, 2020·3 cites·13 claims
- 0576US10815205B2Amide-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Oct 27, 2020·2 cites·13 claims
- 0675US10722501B2Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereofBAYER AG·Filed 2017·Granted Jul 28, 2020·2 cites·19 claims
- 0771US12503491B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2023·Granted Dec 23, 2025·0 cites·8 claims
- 0870US11091463B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2019·Granted Aug 17, 2021·0 cites·9 claims
- 0964US2019144423A1Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1062US11667675B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2020·Granted Jun 6, 2023·0 cites·3 claims
- 1158US10703742B2Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivativesBayer Pharma AG·Filed 2017·Granted Jul 7, 2020·0 cites·10 claims
- 1258US2020299271A1Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- triazole derivativesBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1352US2024010684A1Masp inhibitory compounds and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 1449US2021253557A1Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Application pending·0 cites
- 1548US11149023B2Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Oct 19, 2021·0 cites·11 claims
- 1646US11331314B2Amine substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted May 17, 2022·0 cites·11 claims
- 1746US10927098B2Hydroxyalkyl-substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Feb 23, 2021·0 cites·11 claims
- 1845US2022144848A1Substituted oxopyridine derivativesBAYER AG·Filed 2019·Application pending·0 cites
- 1944US11298367B2Prodrugs of substituted triazole derivatives and uses thereofBAYER AG·Filed 2018·Granted Apr 12, 2022·0 cites·12 claims
- 2044US11230540B2Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Jan 25, 2022·0 cites·13 claims
- 2142US11173151B2Substituted triazole derivatives and uses thereofBAYER AG·Filed 2018·Granted Nov 16, 2021·0 cites·13 claims
- 2239US2019119251A1Amide-substituted aryltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2338US11337973B2Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitorsBAYER AG·Filed 2018·Granted May 24, 2022·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Neubauer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →